World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
55459
World Ranking
3108
National Ranking
1716

Overview

Michael I. D'Angelica is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on oncology within the medical field, with specific expertise in pancreatic and hepatic oncology, hepatocellular carcinoma treatment and prognosis, and related cancer research.

Their work spans several interrelated subfields including oncology, hepatology, surgery, pulmonary and respiratory medicine, and cancer research. Research topics covered encompass pancreatic and hepatic oncology research, hepatocellular carcinoma treatment and prognosis, cholangiocarcinoma and gallbladder cancer studies, colorectal cancer treatments and studies, cancer genomics and diagnostics, gallbladder and bile duct disorders, and the application of radiomics and machine learning in medical imaging.

Michael I. D'Angelica has co-authored numerous papers with several frequent collaborators. These include T. Peter Kingham, William R. Jarnagin, Jeffrey A. Drebin, Alice C. Wei, and Mithat Gönen, with collaboration counts ranging from 62 to 92 joint publications. Their works have been published extensively in journals such as Annals of Surgical Oncology, HPB, Annals of Surgery, Journal of Surgical Oncology, and Surgery.

Representative recent papers include:

  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer, 2023, Nature
  • Liver metastases, 2021, Nature Reviews Disease Primers
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer, 2025, Nature
  • Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy, 2023, JAMA
  • Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights, 2022, British Journal of Cancer

Best Publications

  • NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

    Al B Benson;Thomas A. Abrams;Edgar Ben-Josef;P. Mark Bloomston

  • The international position on laparoscopic liver surgery: The Louisville Statement, 2008.

    Joseph F. Buell;Daniel Cherqui;David A. Geller;Nicholas O'Rourke

  • Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

    James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong

  • CD133 expression is not restricted to stem cells, and both CD133 + and CD133 – metastatic colon cancer cells initiate tumors

    Sergey V. Shmelkov;Jason M. Butler;Andrea T. Hooper;Adilia Hormigo

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma

    Michael D'Angelica;Mithat Gonen;Murray F. Brennan;Alan D. Turnbull

  • Hepatobiliary cancers, Version 2.2021

    Al B. Benson;Michael I. D'Angelica;Daniel E. Abbott;Daniel A. Anaya

  • Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.

    Michael G. House;Hiromichi Ito;Mithat Gönen;Yuman Fong

  • Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.

    Margo Shoup;Mithat Gonen;Michael D'Angelica;William R Jarnagin

  • Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

    William R. Jarnagin;Leyo Ruo;Sarah A. Little;David Klimstra

  • Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.

    Steven C Katz;Jinru Shia;Kui Hin Liau;Mithat Gonen

  • Impact of steatosis on perioperative outcome following hepatic resection

    David A Kooby;Yuman Fong;Arief Suriawinata;Mithat Gonen

  • Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies

    James J Harding;Subhiksha Nandakumar;Joshua Armenia;Danny N Khalil

  • Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

    Maeve A. Lowery;Ryan Ptashkin;Emmet Jordan;Michael F. Berger

  • Pasireotide for Postoperative Pancreatic Fistula

    Peter J Allen;Mithat Gönen;Murray F Brennan;Adjoa A Bucknor

  • Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

    Michael D'Angelica;Murray F. Brennan;Arief A. Suriawinata;David Klimstra

  • A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients.

    Peter J Allen;Michael D'Angelica;Mithat Gonen;David P Jaques

  • The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.

    Eric L. Eisenhauer;Nadeem R. Abu-Rustum;Yukio Sonoda;Douglas A. Levine

  • Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

    Karen T. Brown;Richard K. Do;Mithat Gonen;Anne M. Covey

  • Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades

    Jordan M. Winter;Murray F. Brennan;Laura H. Tang;Michael I. D’Angelica

Frequent Co-Authors

William R. Jarnagin
William R. Jarnagin Memorial Sloan Kettering Cancer Center
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania
Peter J. Allen
Peter J. Allen Duke University
Yuman Fong
Yuman Fong City Of Hope National Medical Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
T. Peter Kingham
T. Peter Kingham Memorial Sloan Kettering Cancer Center
Nancy E. Kemeny
Nancy E. Kemeny Memorial Sloan Kettering Cancer Center
Leslie H. Blumgart
Leslie H. Blumgart Memorial Sloan Kettering Cancer Center
David S. Klimstra
David S. Klimstra Yale University
Murray F. Brennan
Murray F. Brennan Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing medicine in the USA doesn’t just mean going to medical school. There are several alternative healthcare degrees and career pathways, especially online options, for those interested in the medical field. For example, if you hold a non-nursing bachelor’s degree and want to become an advanced practice nurse, you can explore non nursing bachelor's to msn online programs. These fast-track programs allow career changers to enter the nursing profession at an advanced level.

Individuals who are looking for accessible entry-points to nursing may be interested in nursing schools with high acceptance rates. Some nursing schools also provide additional flexibility by not requiring entrance exams; learn more about do all nursing schools require the teas to find programs without standardized entrance testing.

For those who prefer administrative roles in healthcare, online education is also available. The best online medical billing and coding schools offer accredited programs, some with financial aid options, providing a direct path into a vital and in-demand field.

Best Scientists Citing Michael I. D’Angelica

Trending Scientists